Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability
This study has been completed.
Study NCT00368056   Information provided by Sepracor, Inc.
First Received: August 23, 2006   Last Updated: October 9, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Insomnia
Additional conditions recognized in this trial
Sleep Initiation and Maintenance Disorders
More general conditions related to this trial
Dyssomnias
Mental Disorders
Nervous System Diseases
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
Eszopiclone
Placebo
Sponsors listed in this trial
Sepracor, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services